Among these, PEBP1/STK11 co-expression strongly negatively correlates in all cancer types with enzymes that increase the biosynthesis of fatty acids such as members of the ACSL family (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6). This evidence concerns the gene ACSL4 and cancer.